Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 19/20 | 1.00 |
| ▸ | GSK3B | P49841 | 3/20 | 0.77 |
| ▸ | CDK1 | P06493 | 3/20 | 0.64 |
| ▸ | PRKACA | P17612 | 3/20 | 0.64 |
| ▸ | HIPK2 | Q9H2X6 | 3/20 | 0.64 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.64 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.64 |
| ▸ | TYK2 | P29597 | 2/20 | 0.64 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.64 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.64 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.64 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.64 |
| ▸ | DYRK3 | O43781 | 2/20 | 0.64 |
| ▸ | PRKCG | P05129 | 2/20 | 0.64 |
| ▸ | FER | P16591 | 2/20 | 0.64 |
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.64 |
| ▸ | MARK3 | P27448 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | FLT4 | P35916 | 2/20 | 0.64 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1049374 | 0.90 | CDC7 (1.00) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1049375 | 0.90 | CDC7 (1.00) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1043587 | 0.87 | CDC7 (1.00) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1049815 | 0.84 | CDC7 (1.00) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1050904 | 0.84 | CDC7 (1.00) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1046067 | 0.83 | CDC7 (0.94) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1045779 | 0.82 | CDC7 (0.90) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1045782 | 0.82 | CDC7 (0.90) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1043448 | 0.80 | CDC7 (0.86) | CDC7GSK3BCDK1PRKACAHIPK2 | |
| SCHEMBL1043445 | 0.80 | CDC7 (0.86) | CDC7GSK3BCDK1PRKACAHIPK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2454257-B1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | ABBVIE INC (US) | 2013-08-21 | — | — | EP | disclosed |
| US-8435980-B2 | Pyrrolopyridine inhibitors of kinases | ABBVIE INC. (US) | 2013-05-07 | — | — | US | disclosed |
| EP-2454257-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | Abbott Laboratories (US) | 2012-05-23 | — | — | EP | disclosed |
| WO-2011008915-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | ABBOTT LABORATORIES (US) | 2011-01-20 | — | — | WO | disclosed |
| US-20110015173-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | ABBOTT LABORATORIES (US) | 2011-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015173-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | CDC7, MAP3K7, CDK1 | CDC7 1/4885GSK3B 442/4885CDK1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.